Need professional-grade analysis? Visit stockanalysis.com
$970.67M
N/A
N/A
N/A
Kalvista Pharmaceuticals Inc (KALV) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $20.48, up 4.70% from the previous close.
Over the past year, KALV has traded between a low of $10.76 and a high of $20.86. The stock has gained 66.5% over this period. It is currently 90.3% above its 52-week low.
Kalvista Pharmaceuticals Inc has a market capitalization of $970.67M.
KalVista Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is EKTERLY, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts.
Side-by-side comparison against top Healthcare peers.